Pharmaceuticals, Biotechnology and Life Sciences
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau…
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer…
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif.,…
Activity Report for Quarter Ended June 30, 2025 (Appendix 4C)NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO;…
Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New…
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company…
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that…
PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) — Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and…